Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration

PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

February 28, 2028

Conditions
THCCannabisCannabis UseCannabis SmokingTobacco UseVaping
Interventions
DRUG

Cannabis

Participants will vape marijuana in varying doses from the PAX device

DRUG

Nicotine

Participants will vape Regular and Very Low Nicotine content cigarettes from the PAX device

DEVICE

Pax Loose Leaf Vaporizer

In all arms, participants will be using the PAX Loose Leave Vaporizer.

OTHER

Placebo Marijuana

Participants will vape placebo marijuana from the PAX device

Trial Locations (1)

94110

RECRUITING

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Food and Drug Administration (FDA)

FED

lead

University of California, San Francisco

OTHER

NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration | Biotech Hunter | Biotech Hunter